242677 ⎘
Methods of treating eye diseases associated with inflammation and vascular proliferation
#2Methods of treating eye diseases associated with inflammation and vascular proliferation
#3METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION
#4Methods of treating eye diseases associated with inflammation and vascular proliferation
#5Synthetic anti-inflammatory peptides and use thereof
#6Compositions and methods for treatment
#7Compositions and methods for treatment
#8Cyclodextrin nanotechnology for ophthalmic drug delivery
#9Compositions and methods for treatment
#10Compositions and methods for treatment
#11Eye drop composition for prevention and treatment of ophthalmic diseases containing fusion protein of FK506 binding protein
#12Methods of treating eye diseases associated with inflammation and vascular proliferation
#13Treatment of eyelid dermatitis
#14Compositions and methods for treatment of eye disorders
#15CYCLODEXTRIN NANOTECHNOLOGY FOR OPHTHALMIC DRUG DELIVERY
#16Compositions and methods for treatment
#17Compositions and methods for treatment
#18Compositions and methods for treatment of eye disorders
#19COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#205-HTreceptor antagonists
#215-HTreceptor antagonists
#22Method of treating inflammation of the eye
#23Methods and compositions for treatment of macular and retinal disease
#24Cyclodextrin nanotechnology for ophthalmic drug delivery
#25Compositions and methods for treatment of eye disorders
#26Treatment of mucosal membranes
#27Estrogenic compounds as anti-mitotic agents
#285-HT7 receptor antagonists
#29Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
#30Therapeutic treatments using the direct application of antimicrobial metal compositions
#31Treatment of inflammatory skin conditions
#32Preserved pharmaceutical compositions comprising cyclodextrins